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Abstract: An extension of the constant pH method originally implemented by Mongan et al.
(J. Comput. Chem. 2004, 25, 2038-2048) is proposed in this study. This adapted version of
the method couples the constant pH methodology with the enhanced sampling technique of
accelerated molecular dynamics, in an attempt to overcome the sampling issues encountered
with current standard constant pH molecular dynamics methods. Although good results were
reported by Mongan et al. on application of the standard method to the hen egg-white lysozyme
(HEWL) system, residues which possess strong interactions with neighboring groups tend to
converge slowly, resulting in the reported inconsistencies for predicted pKa values, as highlighted
by the authors. The application of the coupled method described in this study to the HEWL
system displays improvements over the standard version of the method, with the improved
sampling leading to faster convergence and producing pKa values in closer agreement to those
obtained experimentally for the more slowly converging residues.
Introduction
It is well-known that the structure and function of a protein
are highly dependent on the pH of its surrounding aqueous
environment due to pH-mediated changes in the protonation
state of titratable residues. The protonation state of a titratable
residue in a protein is determined by its pKa and the solution
pH, the former being a measure of the relative acidity of the
residue, which is inﬂuenced by interactions with neighboring
residues, including titratable residues. These changes in
protonation equilibrium, which are essentially of electrostatic
nature, are closely linked with the conformation and are
fundamental in the deﬁnition of the often-narrow pH range
for the functioning protein, beyond which unfavorable
conformational change and denaturation of the protein
structure may occur.
The important pairing of protonation state and protein
conformation is not accounted for in standard molecular
dynamics (MD) simulations. Currently, the majority of
standard simulations of biological systems use ﬁxed, prede-
termined protonation states for titratable residues, which are
generally based on the pKa values of the isolated residue in
solution. In addition, protonation states are usually assigned
during the preparation of the system and are not changed
throughout the standard MD simulation. This method of
protonation state assignment is a severe approximation, as
the pKa values of titratable residues are frequently shifted
from that of the model residue in solution, making the
assignment a nontrivial task. Furthermore, protonation states
are not single constant values; they are subject to the
changing electrostatic environment surrounding the titratable
group. Therefore, incorporating pH as an input variable in
MD simulations is highly desirable, as it would allow a more
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such as reaction mechanisms, ligand binding, and the
determination of the structure and function of proteins as a
function of pH.
Over approximately the past 15 years, several methods
have been proposed which enable MD to be carried out at a
constant pH with changing protonation states. These constant-
pH MD (CpHMD) methods can be largely classiﬁed into
two categories, discrete
1-4 and continuous.
5-7 Several
reviews have been published which compare and contrast
the different methods.
8-10 In the following paragraphs, a
brief description of some of these methods is given.
Continuous protonation state models, such as that of
Bo ¨rjesson and Hu ¨nenberger
6,7 and Baptista et al.,
5 consider
protonation state as a continuous titration parameter, which
advances simultaneously with the atomic coordinates of the
system. However, these methods use a mean-ﬁeld ap-
proximation, whereby they do not take into account any
interaction with other nearby titratable residues that may
occur, and the titratable groups are represented by fractional,
nonphysical protonation states, intermediate between the
protonated and unprotonated forms.
11,12 These factors cause
the models to perform poorly for tightly coupled residues
7
and result in inadequate estimation of physical observables.
The more recent work of Lee et al.
13 overcomes the issues
with unphysical fractional protonation states with the use of
λ dynamics with the addition of an artiﬁcial titration barrier
along the continuous titration coordinate between the fully
protonated and deprotonated end points. This has the effect
of forcibly lengthening simulation time in the fully protonated
or deprotonated values. The authors report good correlation
between the predicted and experimental pKa values for the
hen egg-white lysozyme (HEWL), turkey ovomucoid, and
bovine pancreatic trypsin inhibitor, although convergence
issues were encountered for these systems, and even for the
simpler aspartate model. Khandogin and Brooks
14 developed
an extension to this method, a two-dimensional λ-dynamics
method using GBSW
15 solvation. The two dimensions are
the two reaction coordinates: the deprotonation process and
the interconversion between proton tautomers, to account for
proton tautomerism in simulations involving histidine and
carboxyl residues. The authors observe signiﬁcant quantita-
tive improvement over the previous work of Lee et al.
13 and
note that the method could be further improved with
enhanced sampling and an improved solvent model. In other
work by the same group,
16 the continuous titration method
is coupled with replica exchange (coupled method known
as REX-CPHMD), used with an improved GB solvent
model
17 and a salt-screening function, to achieve more
accurate predictions of pKa shifts when applied to 10 test
protein systems, all possessing residues with signiﬁcant pKa
shifts.
The majority of the more recent studies have involved
the use of discrete protonation state models, which avoid
the nonphysical intermediate charge states. These methods
use MD simulations for conformational sampling, with
periodic sampling of discrete protonation states through
trial Monte Carlo (MC) moves. The main differences
between these methods lie in their choice of solvent model
and the protocol for updating the protonation states.
1-4
The methods employing explicit solvent are computation-
ally expensive, and MC trial moves are attempted
relatively infrequently, causing long convergence times
for systems with multiple titration sites. Both Bu ¨rgi et
al.
18 and Baptista
1 et al. developed methods using explicit
solvent. Baptista et al. used Poisson-Boltzmann (PB)
electrostatics for the calculation of protonation state
energies to be used for the MC test. However, the PB
calculations are time-consuming and introduce a solvent
potential different from that used for the explicit-solvent
dynamics. Bu ¨rgi et al. avoid the discrepancy in the
potentials with the use of thermodynamic integration (TI)
under the same explicit solvent conditions as used for the
dynamics, to determine the transition energies for the MC
test. However, this has the effect of perturbing the
trajectory, even when the MC trial is rejected, since the
ﬁnal trajectory is formed from the concatenation of
the TI segments. In addition, the length of time over which
the TI calculations are performed (∼20 ps) makes their
signiﬁcance uncertain, and the expense of explicit solvent
is a probable contributor to the apparent poor convergence
of the simulations.
8 Stern introduces a method whereby
the issues associated with instantaneous protonation state
change when using explicit solvent are circumvented, with
the use of a hybrid Monte Carlo procedure.
19 In this
method, the trial moves comprise relatively short MD
trajectories, which employ a time-dependent potential
energy that interpolates between the old and new proton-
ation states. The method has been successfully applied to
acetic acid in water but has not yet been applied to protein
systems.
Methods employing implicit solvent for both the
dynamics and MC steps include the work of Dlugosz and
Antosiewicz,
2,3 who use PB calculations in the calculation
of transition energies, and the analytical continuum
electrostatics (ACE/GB) model of CHARMM for dynam-
ics. Again, this method has the problems associated with
the expense of PB calculations and the mismatch in
potentials used, although the method reports fair agreement
with experiment when applied to a heptapeptide derived
from the ovomucoid third domain and succinic acid.
Mongan et al. use GB solvation for both the MC steps
and the dynamics,
4 therefore avoiding the discrepancy in
the potentials used, with pKa predictions agreeing well
with experimental results on application to the HEWL
system, although convergence issues are noted for some
residues of the system.
In this work, we propose an extension to the constant pH
model of Mongan et al., whereby the methodology is coupled
with the enhanced sampling technique of accelerated mo-
lecular dynamics (aMD) to increase the sampling and
alleviate the reported convergence issues. This version of
the method has been implemented in AMBER8 and has been
applied to the popular test case, the HEWL system. The
results show improvement in the sampling compared with
the standard Mongan et al. method, with pKa results close
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more slowly converging residues.
Background
The standard constant pH (Mongan et al.) and aMD methods
(de Oliveria et al.) coupled in this study are described in
detail elsewhere, and so only outlines of the techniques are
given here. The CpHMD method described here differs from
the standard method in that the sections of conventional MD
are replaced with the enhanced sampling technique, aMD.
The combined method is denoted as CpHaMD in this work.
The method employs GB-solvated aMD with periodic MC
sampling of protonation states, also using the same GB
electrostatics. At each MC step, a titratable residue and a
new protonation state are chosen at random, with the total
transition energy, ∆G, being used as the Metropolis criterion
for the decision of protonation state. The calculation of ∆G
is shown in eq 1, where kB is the Boltzmann constant, T is
the temperature, pH is the speciﬁed solvent pH, pKa,ref is the
pKa of the reference compound, ∆Gelec is the electrostatic
energy component of the titratable residue, and ∆Gelec,ref is
the electrostatic component of the transition energy for the
reference compound. If the MC move is accepted, the
protonation state of the residue will change to the new state
and MD is continued; if not, the simulation will continue
with the residue remaining in the unchanged protonation
state.
In the previous implementation of the method, conven-
tional MD was employed between the MC steps. In the
version of the method reported in this work, standard MD
is replaced with aMD. As mentioned previously, a limitation
of constant pH methods is often convergence,
8,16 therefore
implying the performance of the method may be improved
by the use of enhanced sampling techniques, as shown by
Khandogin and Brooks with their REX-CPHMD method.
16
Here, a recently modiﬁed version of the dual-boost aMD
method (referred to as aMDtTb in the literature) by de
Oliveira et al. is used (a modiﬁcation of the Hamelberg et
al. aMD methodology
20), which has been found to be useful
in improving the accuracy and convergence of TI simulations.
This approach increases conformational sampling through
the modiﬁcation of the energy landscape by lowering energy
barriers while leaving the potential surface in the vicinity of
the minima unchanged. The energy barriers are reduced
through the application of a boost potential, ∆V(r), to the
true potential surface, V(r), in cases where the true potential
exceeds a predeﬁned energy level, E. The boost potential is
implemented in the method according to eq 2, where R
modulates the shape of the modiﬁed potential (lower values
of R result in a ﬂatter modiﬁed potential, and higher values
approach the unmodiﬁed potential).
In cases where the true potential exceeds the boost energy
level E, the boost potential is subtracted from the true
potential, and the simulation is performed on this modiﬁed
potential surface V*(r) ) V(r) - ∆V(r). At times where the
true potential lies below the boost energy level, E, the
simulation is performed on the true potential, V*(r) ) V(r).
In this work, the dual-boost approach
21 has been used in
order to increase the sampling of both the torsional degrees
of freedom and the atomic packing arrangements. The ﬁrst
boost is applied to only the torsional terms, Vt(r), and the
second boost is added to the total potential energy, VT(r) )
V0(r) + Vt(r) (eq 3).
The correct canonical averages of an observable, in this
case pKa, are calculated from conﬁgurations sampled on the
modiﬁed potential energy surface and are fully recoverable
by reweighting each point in conﬁguration space by eq 4.
Test Case: Hen Egg White Lysozyme
HEWL is a 129-residue monomeric single-domain enzyme
which catalyzes the hydrolysis of polysaccharides found in
many bacterial cell walls (see Figure 1). The enzyme is
known to possess several residues with pKa values signiﬁ-
cantly shifted from the model isolated residue values.
22,23
Additionally, it is a well-known example of an enzyme which
employs a proton donor and a catalytic nucleophile (Asp 52
and Glu 35)
24 within the active site, located in a cleft between
an all-R and a  -rich region. Owing to extensive experimental
study of this system, and the challenging nature of the pKa
shifts of some of the residues, HEWL has been a popular
test system for many of the pKa calculation methods. In this
study, focus is placed on the acidic residues of this enzyme,
which have been experimentally determined to possess the
most signiﬁcant pKa shifts of the system.
Molecular Dynamics Simulations
The standard CpHMD and coupled CpHaMD methods have
been implemented in the AMBER 8 molecular dynamics
∆G ) kBT(pH - pKa,ref)ln 10 + ∆Gelec - ∆Gelec,ref
(1)
∆V(r) ) {
(V(r) - E)
2
R+(V(r) - E)
, V(r) g E
0, V(r) < E
(2)
Figure 1. The HEWL enzyme (PDB ID: 1AKI) with titratable
groups highlighted in liquorice style (aspartates, blue;
glutamates, red; and histidine, orange).
V*(r) ) {V0(r) + [Vt(r) - ∆Vt(r)]} - ∆VT(r) (3)
exp{- [∆Vt(r) + ∆VT(r)]} (4)
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al., and the parameters used match those used in their work.
All simulations described employed the AMBER99 force-
ﬁeld
25 and the GB solvent model
26-28 (igb)2). Salt con-
centrations were set at 0.1 M, and a 30 Å cutoff value for
nonbonded interactions and effective Bond radii calculations
was used. The SHAKE algorithm was used to constrain all
bonds involving hydrogen, allowing a time step of 2 fs to
be used. The temperature was maintained at 300 K using
the Berendsen temperature coupling method with a time
constant of 2 ps. A period of 10 fs of MD or aMD separated
the MC trials.
For the HEWL system, values for the boost energy, E,
applied to the torsional degrees of freedom and the total
potential energy were estimated on the basis of the average
torsional and total potential energies and the root mean square
(RMS) deviation in these energies over CpHMD simulations
carried out on the unmodiﬁed potential at the pH of interest.
The parameter, E, was calculated from subtracting the sum
of twice the RMS deviation from the average potential and
torsional energies. The value of the R parameter for the total
potential energy was estimated to be ∼5 kcal/atom, and for
the torsional potential, a value of ∼30% of the average
dihedral potential energy, obtained from the simulation
carried out on the unmodiﬁed potential, was found to be
efﬁcient.
All simulations were started from the minimized 1AKI
(PDB ID) crystal structure, as prepared by Mongan et al.
(details given in ref 4). Simulations of 5 ns in length were
carried out in the pH range 2-6.5 at 0.5 pH unit intervals,
using both CpHMD and CpHaMD methods. GLU and ASP
residues were set to titrate from pH 2.0 to pH 6.5, with the
addition of HIS residues from pH 4.5 to pH 6.5. HIS residues
were not set to titrate for the most acidic simulations, as
they are likely to remain in the protonated state in this pH
range, as indicated by its model pKa value of 6-7.
29 Models
for the terminal residues have not been developed yet for
this system, so these residues were set to their neutral
protonation states. This approximation has been deemed to
be sufﬁcient for these simulations, as explained in the prior
work on this system, by Mongan et al. All nontitrating
residues were set to their expected protonation states.
Extended Simulations. To further investigate the effects
of CpHaMD, simulations at pH 3 and pH 6.5 were extended
to 40 ns in triplicate, the further two simulations initialized
from different random seeds, and generated from re-
equilibration of the minimized structure. The pH values were
chosen as they represented two different regions of the acidic
pH range, pH 3 being close to the experimental pKa values
for the majority of the residues and pH 6.5 being more
challenging in obtaining convergence and accurate pKa
evaluations due to the many residues of interest being in the
deprotonated state.
Principal Component Analysis (PCA). Details of PCA
can be found elsewhere in the literature.
30,31 The GROMACS
analysis program,
32 g_covar, was used for the calculation
and diagonalization of the covariance matrix, with the
analysis of the resultant eigenvectors performed using
g_anaeig. The covariance matrix of positional ﬂuctuation was
calculated for atoms of the residue of interest and atoms in
the vicinity, within a distance 7.5 Å, from the 12 concat-
enated trajectories of 40 ns (CpHMD: pH 3.0, three simula-
tions; pH 6.5, three simulations; CpHaMD: pH 3.0, three
simulations; pH 6.5, three simulations). The two-dimensional
plots were generated from the projection of the trajectories
onto the ﬁrst two eigenvectors.
Results
Simulation Stability. Initially, simulations of 5 ns in
length were performed (as described in the Molecular
Dynamics Simulations section). Figure 2 monitors the root-
mean squared deviation (RMSD) of the CR atoms, with
respect to the crystal structure, over the duration of the 5 ns
simulations at pH 2.0, 4.0, and 6.0. Simulations employing
the standard CpHMD and the adapted CpHaMD method are
Figure 2. The RMSD of CA atoms with respect to the crystal structure, over the duration of 5 ns simulations carried out at pH
2.0, 4.0, and 6.0 using CPH-aMD (lower plot) and CpHMD (upper plot).
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over the 5 ns. This is in agreement with experimental
evidence; the HEWL enzyme has been experimentally
reported to be stable over a wide range of pH values,
including a pH stability screen carried out in the range of
pH 3-8 which revealed HEWL to be very stable at pH 4, 5,
and 8.
33
pKa Predictions Calculated from 5 ns Simulations. A
summary of pKa predictions for residues titratable over the
acidic pH range, calculated from the set of 5 ns simulations
performed in this study, is shown in Table 1. At each pH
value, the predicted pKa was calculated according to the
Henderson-Hasselbach equation, with the ratio of time that
a titratable group spends in the protonated and deprotonated
states used as a ratio of concentrations. For CpHaMD
simulations, each state is reweighted by eq 4, before the ratio
of concentrations is calculated. For comparison with experi-
mental pKa values, a composite pKa value for each residue
was obtained from the combination and averaging of the
individual pKa values generated at the various pH conditions
by the CpHaMD and CpHMD simulations.
Over the pH range studied, the simulations predict pKa
values of titratable residues which correlate well with
experimental values (good correlation is deemed as <1p Ka
unit deviation from the experimental range given in ref 34).
However, both methodologies predict pKa values which
deviate more than 1 pKa unit from the experimental results
for several residues (highlighted in bold in Table 1), and
signiﬁcant variation is observed for some residues between
predictions made for the same residue at different pH values
(for example, the calculated pKa for ASP-52 at pH 4.5 is
-0.1, and that at pH 5.5 is 3.27), indicating a lack of
convergence for these residues.
Mongan et al.
4 employed the constant-pH method for a
set of 1 ns simulations of the HEWL system and reported
pKa predictions for a range of pH values. As observed in
this study, they also obtain good overall calculated pKa values
with inconsistency in predictions obtained from different
simulations for some of the more strongly interacting
titratable groups. They suggest one limitation of the method
to be its inability to sufﬁciently sample conformational space,
as, due to the dependence of instantaneous pKa on conforma-
tion, limited conformational sampling would restrict the
accuracy of pKa prediction, especially for the more slowly
converging residues of the system (e.g., the more buried Asp-
52 and Glu-35 residues). In this study, measurement of the
calculated pKa over the duration of the simulations reported
here (Figure 3) shows that 5 ns is still an insufﬁcient
simulation time to observe convergence for all residues, even
for simulations using the enhanced sampling methodology.
The most problematic case across the pH range is shown
to be ASP-52, one of the catalytically crucial residues,
residing within the active site (see Figure 1). Residues located
within the protein experience a very different electrostatic
environment from the isolated model residue, resulting in
signiﬁcant shifts in pKa. It is common for such residues to
form strong interactions with residues in the vicinity, which
often causes sampling problems with the use of conventional
MD, owing to the slower convergence of these residues. In
addition to convergence issues, deﬁciencies in the GB solvent
model used have been highlighted in the literature.
16 For
buried residues, the GB model underestimates the desolvation
energy and buried charge-charge interactions owing to
neglect of the solvent excluded volume. Although an
improved GB model would certainly improve results, this
study is only focused on the sampling issues associated with
the constant pH method and improvement of results with
the use of enhanced sampling. In the case of ASP-52, an
interaction with ASN-46 is shown to persist for the duration
of several simulations, causing the calculated pKa to be
Table 1. pKa Predictions of Titratable Residues of the HEWL Enzyme over the Acidic pH Range
a
simulation pH
residue pH 2.0 pH 2.5 pH 3.0 pH 3.5 pH 4.0 pH 4.5 pH 5.0 pH 5.5 pH 6.0 pH 6.5 av. exptl. value
ASP-18 2.62 2.92 2.47 2.24 2.41 2.34 2.58 2.38 -- 2.50 2.66
(2.50) (2.99) (2.53) (1.69) (2.07) (2.27) (2.15) (2.78) (2.26) (-) (2.36)
ASP-48 2.70 0.35 2.83 2.38 3.34 1.98 1.96 3.06 1.32 2.01 2.19 2.50
(2.39) (2.23) (2.70) (2.82) (2.86) (3.24) (0.30) (3.42) (2.66) (1.80) (2.44)
ASP-52 1.99 1.17 2.36 2.17 2.14 -0.1 1.34 3.27 3.37 4.71 2.24 3.68
(2.18)( 2.45)( 2.52)( 1.33)( 1.72)( 2.45)( 2.25) (2.87) (-)( 2.57)( 2.26)
ASP-66 2.71 3.28 2.47 2.15 3.12 2.14 2.62 2.31 2.52 2.93 2.63 2.00
(2.89) (2.79) (2.87) (2.59) (3.44)( 3.43)( 1.79)( -) (2.14) (2.50) (2.72)
ASP-87 2.51 2.25 2.38 1.76 2.25 2.69 2.43 2.85 3.29 3.21 2.56 2.07
(2.42) (2.41) (2.91) (2.80) (2.70) (1.84) (3.00) (2.21) (3.23) (3.18) (2.67)
ASP-101 3.46 3.42 2.82 3.17 3.93 2.88 3.45 3.73 - 3.63 3.50 4.09
(3.19) (3.29) (2.39) (3.12) (2.59) (3.24) (3.48) (3.96) (3.33) (3.91) (3.25)
ASP-119 2.07 3.55 2.25 2.52 2.50 2.35 2.64 1.92 2.36 1.21 2.34 3.20
(2.73) (2.08) (2.21) (2.90) (2.36) (2.45) (2.17) (3.06) (2.00) (2.40) (2.44)
GLU-7 3.62 3.77 3.61 3.66 3.70 3.67 3.77 3.81 3.85 3.56 3.70 2.85
(3.64) (3.53) (3.73) (3.63) (3.70) (3.60) (3.80) (3.68) (4.11) (4.12) (3.75)
GLU-35 5.51 5.76 6.06 5.61 5.02 6.22 4.92 5.13 4.72 4.54 5.35 6.20
(4.65)( 4.75)( 4.76) (5.79) (4.17) (6.33) (5.51) (3.05) (5.91) (5.46) (5.04)
HIS-15 NM NM NM NM NM 3.94 5.20 5.48 6.52 7.25 5.68 5.71
(4.09) (5.47) (4.85) (7.28)( 7.45) (5.83)
a Results generated using the standard constant-pH methodology (lower values) and using the aMD-modiﬁed approach (upper values).
Average values (av.) were calculated for each residue from 5 ns simulations performed at the indicated pH values. The pKa of HIS-15 was
not measured (NM) at lower pH values. Where a value is missing (-), the pKa of that residue was unable to be measured owing to zero
transitions in protonation state occurring over the duration of the simulation. Values highlighted in bold are >1 pKa unit from the
experimentally reported range.
34
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of 3.6-3.76. As also observed in the constant-pH study of
Mongan et al., persistent interactions with neighboring
residues also exist with GLU-35, but to a lesser degree when
compared with ASP-52.
RMS Error Analysis. The RMS error was calculated for
groups of residue types, with respect to the midpoint of the
experimental value range
34 (Table 2). The RMS error was
also calculated for the null model, against which both
methods are shown to perform considerably better.
As stated earlier, although the simulations do not appear
to have reached convergence for all residues, overall, the
CpHaMD method is indicated to predict pKa values which
are closer to experimental results, conﬁrmed by the lower
RMS error values reported in Table 2. The RMS error for
the single histidine residue included in the calculations has
the lowest error and is reported experimentally to only have
a small shift in pKa from the model compound. This histidine
residue resides on the surface, away from the active site,
and possesses interactions with neighboring residues, includ-
ing Thr-89, which are overestimated in a few of the
simulations, resulting in the higher predicted pKa values. The
groups of aspartates and glutamates both contain residues
exhibiting larger pKa shifts and reside in more buried
locations of HEWL, resulting in the relatively higher RMS
errors.
In addition, the results of both the CpHMD and CpHaMD
methods are shown to perform well on comparison with those
achieved using other CpHMD methodologies (Table 3),
where the leading results have RMS errors in the range of
0.65-0.8 for the acidic residues. The constant-pH methods
achieving good results when applied to the HEWL system
include the more recent method of Khandogin and Brooks,
16
who combine the constant-pH method with replica exchange
and an improved GB implicit solvent model, attaining pKa
predictions with a RMS error of 0.65 and 1.19 (RMS error
calculated from simulations including and excluding salt
effects, respectively). Machuqueiro and Baptista
35 achieve
a RMS error value of 0.84 with the inclusion of proton
tautomerism in their CpHMD method, and incorporating the
generalized reaction ﬁeld (GRF) for the treatment of long-
range electrostatics. The RMS error increases to 0.79-0.93
when changing to the particle-mesh Ewald (PME) algorithm.
Bu ¨rgi et al.
18 use constant-pH with TI and MC for the
protonation state determination and achieve only qualitative
pKa results, denoted by a RMS error of 2.97, which has been
attributed to inadequate simulation time for convergence.
Good results have also been achieved for HEWL using
Poisson-Boltzmann-based pKa calculations.
36-42 However,
no good method has yet been developed which accounts for
signiﬁcant conformational change, and generally, the current
methods are likely to be insufﬁcient in cases where confor-
mational change has a large inﬂuence on residue pKa.
11 The
Figure 3. pKa values of titratable residues over the duration of 5 ns simulations employing CpHMD (top two plots) and CpHaMD
(lower two plots) at pH 3.0 (plots a and c) and pH 6.5 (plots b and d).
Table 2. RMS Error of pKa Values Calculated from 5 ns
Simulations over the pH Range of 2-6.5, with Respect to
the Mid-Point Experimental pKa Value
RMS error
CpHaMD CpHMD null model
all residues 0.73 0.80 1.39
aspartates 0.75 1.46 1.34
glutamates 0.85 1.04 1.68
histidine 0.03 0.12 0.69
Table 3. RMS Error Values Calculated for Acidic Residues
of HEWL Listed in Table 1
a
methodology RMS error
null model 1.39
Bu ¨rgi et al. (2002)
18 2.97
Lee et al. (2004)
13 2.28
Mongan et al. (2004)
4 0.82
Khandogin and Brooks (2006)
16 0.65,
b 1.19
c
Machuqueiro and Baptista (2008)
35 PME: 0.79-0.93;
d GRF: 0.84
this work CpHMD: 0.8; CpHaMD: 0.73
e
a Values calculated with respect to the mid-point of the
experimental range given in ref.
34 b Calculated from simulations
carried out in the implicit solvent model in the presence of salt
effects.
c Carried out in the implicit solvent model in the absence
of salt effects.
d Range of values for the dielectric constant used.
e Calculated from 5 ns CpHaMD simulations.
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since they incorporate ﬂexibility and offer the ability to study
the dynamics of pH-dependent phenonoma.
Extended Simulations. Simulations were extended to 40
ns and performed in triplicate for two pH values in different
regions of the acidic pH range (pH 3.0 and pH 6.5),
increasing the opportunity for conformational change and,
thus, to test whether a further increase in conformational
sampling would improve the accuracy of the pKa prediction
for the more challenging residues.
As Figure 4 demonstrates, the extended simulations
carried out using the CpHaMD method appear to converge
faster and progress closer toward the experimental values
for a larger number of residues when compared with
simulations carried out using the standard CpHMD
method. This is especially pronounced for simulations
carried out at pH 3.0, which is expected, since the majority
of the experimental pKa values lie closer to this pH. At
pH 6.5, the majority of the measured residues are in the
deprotonated state, and the calculation of the pKa becomes
very sensitive as a result of the relative magnitude of
unprotonated to protonated states becoming very small,
due to the considerably smaller number of transitions
between protonation states.
The pKa predictions for the previously mentioned
problematic residue, ASP-52, are signiﬁcantly improved
using the CpHaMD method, with all six simulations (three
simulations at pH 3 and three simulations at pH 6.5)
generating values within 1 pKa unit of the experimental
range (see Table 4). A greater variation, indicated by the
larger standard deviations, is observed between the
simulations employing the standard CpHMD method, with
no value at all calculated for two of the three simulations
carried out at pH 6.5. For these simulations, the residue
has a strong tendency to become stuck in the deprotonated
state, owing to a continued hydrogen bond with residue
ASN-46. This interaction is present in the crystal structure
and was noted to persist in the study using the standard
version of this constant pH method.
4 ASN-46 resides in
a loop region of HEWL, which does not display signiﬁcant
mobility in the CpHMD simulations. However, in simula-
tions employing CpHaMD, this region undergoes increased
conformational motion, as highlighted by the larger
sampling area of the CpHaMD simulations, shown in the
two-dimensional plots, generated from PCA analysis
(Figure 5). This increased loop motion facilitates the
dissociation of the interaction between the two residues,
as when the loop moves away, the interaction is lost and
ASP-52 is able to interchange to the protonated state
(Figure 6). Within CpHaMD simulations, the aforemen-
tioned interaction is observed to repeatedly dissociate and
reform, depending on local conformational change, il-
lustrated by the number of transitions occurring between
the protonated and deprotonated forms of the residue
throughout the simulation (example shown in Figure 7).
Over the three CpHaMD simulations at pH 6.5, an average
of 181 transitions were recorded, whereas for the one
CpHMD simulation at pH 6.5, for which a pKa could be
calculated, only two transitions took place throughout the
40 ns of CpHMD simulation. For less problematic
residues, the number of transitions is far higher during
CpHMD simulations at 6.5, with >10 000 transitions
recorded for some residues.
Overall, the initial application of this newly coupled aMD
enhanced sampling technique to the standard constant pH
methodology of Mongan et al. signiﬁes the CpHaMD
technique to be promising in improving the convergence of
constant-pH simulations, providing more accurate pKa pre-
Figure 4. pKa values of titratable residues over the duration of 40 ns CPMD (top two plots) and CpHaMD (lower two plots)
simulations at pH 3.0 (plots a, c) and pH 6.5 (plots b, d).
Table 4. Average pKa Predictions Calculated from Three
40 ns Simulations Using CpHMD and CpHaMD Methods
a
CpHMD CpHaMD
residue pH 3.0 pH 6.5 pH 3.0 pH 6.5
exptl.
value
ASP-52 2.47 (1.19) 1.67 (-) 3.73 (0.67) 3.62 (0.78) 3.68
a The standard deviation is noted in brackets. (-) indicates pKa
prediction only possible in one of three simulations.
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pH conditions.
Conclusions
This study has introduced a new technique whereby the
CpHMD method of Mongan et al.
4 has been coupled with the
aMD enhanced sampling method of de Oliveira et al. and
Hamelberg et al.
20,43 This coupled technique substitutes the
conventional MD employed in the standard CpHMD method
with aMD, a method previously demonstrated to enhance
sampling by lowering the energy barriers of the energy
landscape, while leaving the minima unchanged, with the
capability of fully recovering the correct canonical averages of
observables, in this case, pKa. CpHaMD utilizes the same GB
implicit solvation, with Monte Carlo sampling based on GB-
derived energies as used in the standard method.
The initial results generated in this study show the CpHaMD
method to more efﬁciently sample conformational space
compared with the standard CpHMD method, resulting in faster
convergence of constant pH simulations and improved agree-
ment of calculated pKa values with those obtained experimen-
tally. In addition, the calculated RMS error between the
predicted and experimental pKa values of the acidic residues
of HEWL demonstrate the CpHaMD methodology to generate
results close to the leading results reported in the literature for
other CpHMD methods. Owing to the improved conformational
sampling, this method has proved to be advantageous over the
CpHMD method in obtaining more accurate and consistent pKa
predictions for the more buried residues of the system, which
are typically more problematic to obtain owing to their slow
convergence. This has been highlighted by the considerably
Figure 5. Conformational sampling of residues (502 atoms) within 7.5 Å of ASP-52 demonstrated by PCA analysis. Eigenvectors
generated from the concatenation of trajectories of simulations carried out at pH 6.5. Red: sampling from simulation carried out
using CpHaMD. Black: sampling from simulation carried out using CpHMD.
Figure 6. Motion of loop allowing the dissociation of the ASP-
52-ASN-46 interaction in simulations employing CpHaMD
methodology.
Figure 7. Transitions between protonated (1) and deprotonated
(0) states of ASP-52 over a 40 ns CpHaMD simulation at pH 6.5.
Coupling Constant pH J. Chem. Theory Comput., Vol. 6, No. 2, 2010 567improved results of the most problematic residue of HEWL,
the catalytically important ASP-52, where the enhanced con-
formational motion observed in the vicinity of this residue in
simulations utilizing CpHaMD clearly demonstrates the link
between protonation state and conformation.
From this initial study, the RMS error measured between the
calculated and experimental results are close to the leading results
reported in the literature for HEWL. It is hoped that this method
would assist in the study of biomolecular systems, in gaining more
accurate thermodynamics and capturing important pH-coupled
conformational events in a more time-efﬁcient manner.
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